FindTrial
Sign In

Construction and application of symptom evaluation scale for patients treated with immune checkpoint inhibitors in non-small cell lung cancer

Construction and application of symptom evaluation scale for patients treated with immune checkpoint inhibitors in non-small cell lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058184
Enrollment
Unknown
Registered
2022-04-01
Start date
2022-05-20
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

None listed

Sponsors

Sun Yat-Sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of non-small cell lung cancer by pathological examination or cytological examination; 2. Are receiving immunotherapy or have received immunotherapy before; 3. Be at least 18 years old; 4. Not accompanied by other cancers; 5. Clear consciousness, basic reading comprehension and audio-visual expression skills; 6. Condition permits and willing to cooperate with investigation.

Exclusion criteria

Exclusion criteria: 1. A history of mental illness; 2. Serious physical illness unrelated to NSCLC; 3. Family members protect the patient's condition; 4. Participating in other clinical trials, and related treatments may affect this study.

Design outcomes

Primary

MeasureTime frame
Symptoms after immunotherapy;—

Countries

China

Contacts

Public ContactSuping Guo

Cancer Center, Sun Yat-Sen University

guosp@sysucc.org.cn+86 15913148518

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026